Literature DB >> 31562393

C/EBPδ-Slug-Lox1 axis promotes metastasis of lung adenocarcinoma via oxLDL uptake.

Dongmei Wang1, Xinghua Cheng2, Yu Li1, Mingwei Guo1, Wenjun Zhao1, Jin Qiu1, Ying Zheng1, Meiyao Meng1, Xiaodan Ping1, Xin Chen1, Shu Wang3, Jian Luo1, Qingquan Luo2, Xinran Ma4,5, Lingyan Xu6,7.   

Abstract

Cancer cells undergo significant lipid metabolic reprogramming to ensure sufficient energy supply for survival and progression. However, how cancer cells integrate lipid metabolic signaling with cancer progression is not well understood. In the present study, we demonstrated that C/EBPδ, a critical lipid metabolic regulator, is a TGF-β1 downstream gene and promotes lung adenocarcinoma metastasis. Importantly, C/EBPδ caused significant oscillations in both lipid metabolic and epithelial to mesenchymal transition (EMT) gene networks. Mechanistically, we demonstrated that C/EBPδ recruited oncogene NCOA3 to transcriptionally activate Slug, a canonical EMT transcription factor, which in turn induced oxLDL receptor-1 (Lox1) expression and enhanced oxLDL uptake to promote cancer metastasis, which could be blocked with LOX1 neutralizing antibody. In summary, our results unveiled a previously unappreciated interplay between lipid metabolic and metastatic program, as well as the existence of a pivotal C/EBPδ-Slug-Lox1 transcription axis to promote oxLDL levels and cancer metastasis.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31562393     DOI: 10.1038/s41388-019-1015-z

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  40 in total

1.  Cancer statistics, 2018.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-01-04       Impact factor: 508.702

Review 2.  Lung cancer in never smokers: clinical epidemiology and environmental risk factors.

Authors:  Jonathan M Samet; Erika Avila-Tang; Paolo Boffetta; Lindsay M Hannan; Susan Olivo-Marston; Michael J Thun; Charles M Rudin
Journal:  Clin Cancer Res       Date:  2009-09-15       Impact factor: 12.531

3.  Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ.

Authors:  A Noto; C De Vitis; M E Pisanu; G Roscilli; G Ricci; A Catizone; G Sorrentino; G Chianese; O Taglialatela-Scafati; D Trisciuoglio; D Del Bufalo; M Di Martile; A Di Napoli; L Ruco; S Costantini; Z Jakopin; A Budillon; G Melino; G Del Sal; G Ciliberto; R Mancini
Journal:  Oncogene       Date:  2017-04-03       Impact factor: 9.867

Review 4.  Evidence, Mechanism, and Clinical Relevance of the Transdifferentiation from Lung Adenocarcinoma to Squamous Cell Carcinoma.

Authors:  Shenda Hou; Shiyu Zhou; Zhen Qin; Liu Yang; Xiangkun Han; Shun Yao; Hongbin Ji
Journal:  Am J Pathol       Date:  2017-03-09       Impact factor: 4.307

Review 5.  Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis.

Authors:  Javier A Menendez; Ruth Lupu
Journal:  Nat Rev Cancer       Date:  2007-10       Impact factor: 60.716

6.  Acetyl-CoA Carboxylase 1-Dependent Protein Acetylation Controls Breast Cancer Metastasis and Recurrence.

Authors:  Marcos Rios Garcia; Brigitte Steinbauer; Kshitij Srivastava; Mahak Singhal; Frits Mattijssen; Adriano Maida; Sven Christian; Holger Hess-Stumpp; Hellmut G Augustin; Karin Müller-Decker; Peter P Nawroth; Stephan Herzig; Mauricio Berriel Diaz
Journal:  Cell Metab       Date:  2017-10-19       Impact factor: 27.287

7.  Targeting metastasis-initiating cells through the fatty acid receptor CD36.

Authors:  Gloria Pascual; Alexandra Avgustinova; Stefania Mejetta; Mercè Martín; Andrés Castellanos; Camille Stephan-Otto Attolini; Antoni Berenguer; Neus Prats; Agustí Toll; Juan Antonio Hueto; Coro Bescós; Luciano Di Croce; Salvador Aznar Benitah
Journal:  Nature       Date:  2016-12-07       Impact factor: 49.962

8.  Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress.

Authors:  Zachary T Schug; Barrie Peck; Dylan T Jones; Qifeng Zhang; Shaun Grosskurth; Israt S Alam; Louise M Goodwin; Elizabeth Smethurst; Susan Mason; Karen Blyth; Lynn McGarry; Daniel James; Emma Shanks; Gabriela Kalna; Rebecca E Saunders; Ming Jiang; Michael Howell; Francois Lassailly; May Zaw Thin; Bradley Spencer-Dene; Gordon Stamp; Niels J F van den Broek; Gillian Mackay; Vinay Bulusu; Jurre J Kamphorst; Saverio Tardito; David Strachan; Adrian L Harris; Eric O Aboagye; Susan E Critchlow; Michael J O Wakelam; Almut Schulze; Eyal Gottlieb
Journal:  Cancer Cell       Date:  2015-01-12       Impact factor: 31.743

Review 9.  Cancer stem cell metabolism: a potential target for cancer therapy.

Authors:  Abhijeet Deshmukh; Kedar Deshpande; Frank Arfuso; Philip Newsholme; Arun Dharmarajan
Journal:  Mol Cancer       Date:  2016-11-08       Impact factor: 27.401

10.  Metabolic reprogramming ensures cancer cell survival despite oncogenic signaling blockade.

Authors:  Hui-Wen Lue; Jennifer Podolak; Kevin Kolahi; Larry Cheng; Soumya Rao; Devin Garg; Chang-Hui Xue; Juha K Rantala; Jeffrey W Tyner; Kent L Thornburg; Ann Martinez-Acevedo; Jen-Jane Liu; Christopher L Amling; Charles Truillet; Sharon M Louie; Kimberly E Anderson; Michael J Evans; Valerie B O'Donnell; Daniel K Nomura; Justin M Drake; Anna Ritz; George V Thomas
Journal:  Genes Dev       Date:  2017-11-14       Impact factor: 11.361

View more
  6 in total

1.  Osteopontin (OPN/SPP1), a Mediator of Tumor Progression, Is Regulated by the Mesenchymal Transcription Factor Slug/SNAI2 in Colorectal Cancer (CRC).

Authors:  Katyana Amilca-Seba; Tuan Zea Tan; Jean-Paul Thiery; Lila Louadj; Sandrine Thouroude; Anaïs Bouygues; Michèle Sabbah; Annette K Larsen; Jérôme A Denis
Journal:  Cells       Date:  2022-05-31       Impact factor: 7.666

2.  Angiogenesis Driven by the CEBPD-hsa-miR-429-VEGFA Signaling Axis Promotes Urothelial Carcinoma Progression.

Authors:  Ti-Chun Chan; Chung-Hsi Hsing; Yow-Ling Shiue; Steven K Huang; Kun-Lin Hsieh; Yu-Hsuan Kuo; Chien-Feng Li
Journal:  Cells       Date:  2022-02-11       Impact factor: 6.600

3.  Expression of Serum sLOX-1 in Patients with Non-Small-Cell Lung Cancer and Its Correlation with Lipid Metabolism.

Authors:  Fangfang Hao; Jinliang Chen; Jinnan Wu; Xin Ge; Xuedong Lv; Dongmei Zhang; Jianrong Chen
Journal:  Can Respir J       Date:  2022-04-11       Impact factor: 2.130

4.  Effect of Oxidized Low-Density Lipoprotein on Head and Neck Squamous Cell Carcinomas.

Authors:  Nadège Kindt; Fabrice Journé; Stéphane Carlier; Anne Trelcat; Alessandro Scalia; Sven Saussez
Journal:  Biomedicines       Date:  2021-05-05

5.  Cell-Penetrating CEBPB and CEBPD Leucine Zipper Decoys as Broadly Acting Anti-Cancer Agents.

Authors:  Qing Zhou; Xiotian Sun; Nicolas Pasquier; Parvaneh Jefferson; Trang T T Nguyen; Markus D Siegelin; James M Angelastro; Lloyd A Greene
Journal:  Cancers (Basel)       Date:  2021-05-20       Impact factor: 6.639

6.  BTBD7 Downregulates E-Cadherin and Promotes Epithelial-Mesenchymal Transition in Lung Cancer.

Authors:  Jie Shu; Lin Wang; Fei Han; Yubin Chen; Shunjun Wang; Fanyan Luo
Journal:  Biomed Res Int       Date:  2019-11-27       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.